Cardinal Capital Management United Therapeutics Corp Transaction History

Cardinal Capital Management

$631 Million
Q3 2024

A detailed history of Cardinal Capital Management transactions in United Therapeutics Corp stock. As of the latest transaction made, Cardinal Capital Management holds 10,860 shares of UTHR stock, worth $3.91 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

10,860

Previous 10,239 6.07%

Holding current value

$3.91 Million

Previous $3.26 Million 19.32%

% of portfolio

0.62%

Previous 0.56%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$311.04 - $363.55 $193,155 - $225,764	621 Added 6.07%	10,860 $3.89 Million
Q2 2024 Jul 12, 2024	BUY	$228.26 - $319.04 $64,825 - $90,607	284 Added 2.85%	10,239 $3.26 Million
Q1 2024 Jul 12, 2024	BUY	$210.76 - $249.51 $353,023 - $417,929	1,675 Added 20.23%	9,955 $2.29 Million
Q1 2024 Apr 15, 2024	BUY	$210.76 - $249.51 $353,023 - $417,929	1,675 Added 20.23%	9,955 $2.29 Million
Q4 2023 Jul 12, 2024	BUY	$214.88 - $256.94 $8,595 - $10,277	40 Added 0.49%	8,280 $1.82 Million
Q4 2023 Jan 26, 2024	BUY	$214.88 - $256.94 $8,595 - $10,277	40 Added 0.49%	8,280 $1.82 Million
Q3 2023 Jul 12, 2024	BUY	$211.82 - $248.24 $30,925 - $36,243	146 Added 1.8%	8,240 $1.86 Million
Q3 2023 Oct 16, 2023	BUY	$211.82 - $248.24 $30,925 - $36,243	146 Added 1.8%	8,240 $1.86 Million
Q2 2023 Jul 12, 2024	SELL	$205.19 - $232.99 $381,858 - $433,594	-1,861 Reduced 18.69%	8,094 $1.79 Million
Q2 2023 Jul 12, 2023	BUY	$205.19 - $232.99 $20,929 - $23,764	102 Added 1.28%	8,094 $1.79 Million
Q1 2023 Apr 18, 2023	BUY	$212.99 - $276.17 $851 - $1,104	4 Added 0.05%	7,992 $1.79 Million
Q4 2022 Jan 20, 2023	BUY	$205.95 - $280.43 $17,505 - $23,836	85 Added 1.08%	7,988 $0
Q3 2022 Oct 21, 2022	BUY	$203.3 - $244.17 $22,159 - $26,614	109 Added 1.4%	7,903 $1.66 Million
Q2 2022 Aug 04, 2022	BUY	$174.81 - $241.14 $14,159 - $19,532	81 Added 1.05%	7,794 $1.84 Million
Q1 2022 Apr 21, 2022	BUY	$166.16 - $213.96 $121,629 - $156,618	732 Added 10.49%	7,713 $1.38 Million
Q4 2021 Jan 18, 2022	BUY	$184.32 - $216.08 $11,980 - $14,045	65 Added 0.94%	6,981 $1.51 Million
Q3 2021 Oct 21, 2021	BUY	$179.86 - $214.88 $20,683 - $24,711	115 Added 1.69%	6,916 $1.28 Million
Q2 2021 Jul 14, 2021	BUY	$170.47 - $211.93 $16,194 - $20,133	95 Added 1.42%	6,801 $1.22 Million
Q1 2021 Apr 19, 2021	BUY	$153.94 - $174.85 $16,933 - $19,233	110 Added 1.67%	6,706 $1.12 Million
Q4 2020 Feb 01, 2021	BUY	$101.87 - $151.79 $31,375 - $46,751	308 Added 4.9%	6,596 $1 Million
Q3 2020 Oct 16, 2020	BUY	$99.9 - $121.13 $36,363 - $44,091	364 Added 6.14%	6,288 $635,000
Q2 2020 Jul 16, 2020	SELL	$92.74 - $125.82 $77,901 - $105,688	-840 Reduced 12.42%	5,924 $716,000
Q1 2020 Apr 20, 2020	BUY	$79.39 - $115.35 $66,846 - $97,124	842 Added 14.22%	6,764 $641,000
Q4 2019 Jan 21, 2020	BUY	$78.31 - $95.34 $463,751 - $564,603	5,922 New	5,922 $522,000

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.3M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.

Account

Cardinal Capital Management United Therapeutics Corp Transaction History